Trials of retooled vaccines for variants could take months: U.S. FDA

vaccine, COVID-19, COVID-19 vaccine

Drugmakers should test any COVID-19 vaccines that have been retooled to combat new variants of the coronavirus in clinical trials designed to track the immune response of hundreds of subjects, which could take months, U.S. regulators said on Monday.

Vaccine developers may need to modify their shots to provide protection against new variants of the coronavirus that turn up in the United States should they fail to elicit an immune response in their current form, the U.S. Food and Drug Administration said in a statement.

The FDA said it believes currently authorized vaccines from Pfizer Inc with partner BioNTech SE and Moderna Inc are effective against variants currently circulating in the United States.

Acting FDA Commissioner Janet Woodcock said drugmakers should not wait until a mutated virus is demonstrated to be able to escape the vaccines to begin developing new versions.

“We need to anticipate this and work on it, so that we have something in our back pocket before the threshold is upon us,” she said at a news conference.

The emergence of new, more contagious variants has prompted the U.S. government to step up efforts to track coronavirus mutations and try to keep vaccines and treatments effective against any new variants.

Pfizer and Moderna have both said they plan to run clinical trials of versions of their vaccines that have been redesigned to combat the highly contagious COVID-19 variant that has become prevalent South Africa and has turned up in several U.S. States.

AstraZeneca Plc, which is running a U.S. trial for its coronavirus vaccine, would be able to quickly adapt to new variants in the laboratory, said Ruud Dobber, company president, North America, in prepared remarks ahead of a U.S. Congressional hearing on Tuesday.

“It is likely the process from start to finished product would take 8 to 9 months to complete. In addition, it will be important to test the effectiveness of the new vaccine against the new variants in a clinical trial,” Dobber said.

The FDA made its comments as part of a newly updated guidance bit.ly/3pEGUPH for companies making vaccines, tests and therapeutics for COVID-19.

As part of the updated guidance, the FDA recommended that vaccine makers test any modified vaccines in both unvaccinated and vaccinated people. The manufacturers should compare the immune response of a modified vaccine against both the new variant as well as the original virus.

The FDA also recommended monitoring test subjects’ safety for at least seven days, to support emergency use authorization for modified vaccines.

The agency is trying to allow drugmakers to make the change with a minimal amount of extra data needed, said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

Still, the type of trial the agency wants, “might take a few months, whether it be two or three,” Marks said. “I can’t say exactly how long but again, that type of the scale of the amount of time.”

“We want to be ready so that we can move it into production, when it’s ready and when it’s needed,” he said.

News Related

OTHER NEWS

Boeing 777 makes emergency landing in Moscow after engine sensor problem

A Rossiya Airlines Boeing 777 cargo plane made an emergency landing at Moscow’s Sheremetyevo airport on Friday due to a problem with an engine control sensor, the airline said. The plane was a... Read more »

Hi, Robot: Japan’s android pets ease virus isolation

Nami Hamaura says she feels less lonely working from home thanks to her singing companion Charlie, one of a new generation of cute and clever Japanese robots whose sales are booming in the... Read more »

Facebook switches news back on in Australia, signs content deals

SYDNEY — Facebook Inc ended a one-week blackout of Australian news on its popular social media site on Friday and announced preliminary commercial agreements with three small local publishers. The moves reflected easing... Read more »

U.S. carries out airstrikes against Iranian-backed militia facilities in Syria: Pentagon

WASHINGTON — U.S. President Joe Biden on Thursday directed U.S. military airstrikes in eastern Syria against facilities belonging to what the Pentagon said were Iran-backed militia, in a calibrated response to rocket attacks... Read more »

FDA allows storage, transport of Pfizer vaccine at higher temperatures

The U.S. Food and Drug Administration on Thursday approved storage and transportation of COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE at standard freezer temperatures for up to two weeks... Read more »

VN urges countries to contribute to maintaining peace, stability in East Sea

VN urges countries to contribute to maintaining peace, stability in East Sea Read more »

Australian media reforms pass parliament after last-ditch changes

CANBERRA — The Australian parliament on Thursday passed a new law designed to force Alphabet Inc’s Google and Facebook Inc to pay media companies for content used on their platforms in reforms that... Read more »

Aussie sheep sheds huge coat after years on the lam

A wild sheep found wandering the wilderness of the Australian bush has been sheared of a huge 35-kilogram (77-pound) coat after an estimated five years of unchecked growth. Struggling under a filthy fleece... Read more »

New coronavirus variant identified in New York: researchers

A new coronavirus variant that shares some similarities with a more transmissible and intractable variant discovered in South Africa is on the rise in New York City, researchers said on Wednesday. The new... Read more »

EU mulls vaccination passports to resurrect tourism after COVID-19

BRUSSELS — European Union leaders will agree on Thursday to work on certificates of vaccination for EU citizens who have had an anti-COVID shot, with southern EU countries that depend heavily on tourism... Read more »